Briefing

Combating respiratory viruses with EHR data: Key use cases for life sciences and public health

Respiratory viruses like influenza, RSV, and COVID-19 continue to challenge global health, demanding innovative solutions to improve prevention, diagnosis, and treatment. Truveta leverages EHR data from over 120 million de-identified patients to transform how life sciences, pharmaceutical, and public health organizations address these challenges.
By providing real-time insights into virus trends, vaccine efficacy, co-infections, and therapeutic development, Truveta empowers researchers with the most complete dataset available, including clinical notes and imaging. This data-driven approach supports innovative healthcare strategies, enhancing outcomes and addressing disparities in at-risk populations.

Download the briefing for insight into:

  • Key EHR data use cases for respiratory viruses
  • Advancements in respiratory virus vaccine development and surveillance
  • Respiratory virus diagnostic and health outcome analyses

Read the briefing now